Yield10 Bioscience stock, agricultural biotechnology

Yield10 Bioscience stock trades OTC after its asset sale

Published on 09/25/2026 at 09:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Yield10 Bioscience stock reflects an asset sale worth up to USD 5 million completed in January 2025. OTC trading showed 0.00 percent daily change on September 9, 2026.

Yield10 Bioscience stock,  agricultural biotechnology,  asset sale,  OTC Markets, Illustration mit AI erstellt.
Yield10 Bioscience stock, agricultural biotechnology, asset sale, OTC Markets, Illustration mit AI erstellt.

Yield10 Bioscience stock stood at USD 0.000100 on OTC Markets on September 9, 2026, with a daily change of 0.00 percent. The company now sits in a very different position from its Nasdaq-listed past, with its core agricultural technology assets transferred to Nufarm.

Asset sale changed the company

Nufarm completed the acquisition of substantially all of Yield10 Bioscience's assets in January 2025 for consideration of up to USD 5 million, according to Green Chemicals Blog. The transaction covered the camelina research portfolio, including omega-3, herbicide-tolerance and bio-energy traits.

The consideration of up to USD 5 million provides a concrete scale for the divestment. It also marks a sharp change from the company's earlier strategy, which centered on developing agricultural biotechnology traits rather than operating a broad commercial seed business.

Nasdaq exit still shapes the quote

Yield10 was forced off Nasdaq in May 2024 after failing to satisfy the exchange's USD 2.5 million minimum equity requirement, the same report stated. Its securities subsequently traded over the counter, placing the USD 0.000100 quote in a market structure distinct from the former Nasdaq listing.

The company's investor-relations page identifies Yield10 as an agricultural bioscience company and showed an OTCQB listing under YTEN in November 2024, according to Yield10 Bioscience. Current market data identify the OTC symbol as YTENQ, while the September 9 quote carried a 0.00 percent daily change.

OTC status defines the stock

The important comparison is structural: the company once traded on Nasdaq, where the minimum equity requirement was USD 2.5 million, but the current quote is an OTC price of USD 0.000100. For investors, the asset transfer and the exchange history matter more than a conventional growth narrative because the transaction removed the company's principal research portfolio from its operating base.

Yield10 Bioscience stock data

Yield10 Bioscience key facts

  • Company: Yield10 Bioscience, Inc.
  • Ticker: YTENQ
  • Trading venue: OTC Markets
  • Price as of September 9, 2026: USD 0.000100
  • Sector / Industry: Agricultural biotechnology

Disclaimer...

en | boerse | 70182267 |